Adjuvant therapy in lymph node-positive vulvar cancer: The AGO-CaRE-1 study

Journal of the National Cancer Institute

Volumn 107, Issue 3, 2015, Pages

  Mahner, Sven ^a   Jueckstock, Julia ^b   Hilpert, Felix ^c   Neuser, Petra ^d   Harter, Philipp ^e   De Gregorio, Nikolaus ^f   Hasenburg, Annette ⁱ   Sehouli, Jalid ^h   Habermann, Annika ^g   Hillemanns, Peter ^j   Fuerst, Sophie ^b   Strauss, Hans Georg ^k   Baumann, Klaus ^d   Thiel, Falk ^l   Mustea, Alexander ^m   Meier, Werner ⁿ   Du Bois, Andreas ^e   Griebel, Lis Femke ^a   Woelber, Linn ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e KLINIKEN ESSEN MITTE   (Germany)

^f UNIVERSITY HOSPITAL ULM   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^j HANNOVER MEDICAL SCHOOL   (Germany)

^k MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^l UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^m UNIVERSITY MEDICINE GREIFSWALD   (Germany)

ⁿ Clinics of Vascular Surgery   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COHORT ANALYSIS; FEMALE; GERMANY; HUMAN; INGUINAL REGION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; VERY ELDERLY; VULVA CANCER; VULVECTOMY; WIDE EXCISION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LYMPH NODE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROGNOSIS; TREATMENT OUTCOME; VULVAR NEOPLASMS;

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; GROIN; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VULVAR NEOPLASMS;

EID: 84930013486     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju426     Document Type: Article

References (29)

1. Beller U, Quinn MA, Benedet JL, et al. Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S7-S27.
2. Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG. New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol. 2008;109(3):340-345.
3. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107(5):1018-1022.
4. Gadducci A, Cionini L, Romanini A, Fanucchi A, AR G. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol/Hematol. 2006;60(3):227-241.
5. Woelber L, Mahner S, Voelker K, et al. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res. 2009;29(2):545-552.
6. Woelber L, Eulenburg C, Choschzick M, et al. Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int J Gynecol Cancer. 2012;22(3):503-508.
7. Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol. 1986;68(6):733-740.
8. Parthasarathy A, Cheung MK, Osann K, et al. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol Oncol. 2006;103(3):1095-1099.
9. Woelber L, Kock L, Gieseking F, et al. Clinical management of primary vulvar cancer. Eur J Cancer. 2011;47(15):2315-2321.
10. Kunos C, Simpkins F, Gibbons H, Tian C, Homesley H. Radiation therapy compared with pelvic node resection for nodepositive vulvar cancer: a randomized controlled trial. Obstet Gynecol. 2009;114(3):537-546.
11. Oonk MH, de Hullu JA, van der Zee AG. Current controversies in the management of patients with early-stage vulvar cancer. Curr Opin Oncol. 2010;22(5):481-486.
12. AGO Kommission Vulva Vagina. Interdisziplinäre S2k Leitlinie für die Diagnostik und Therapie des Vulvakarzinoms und seiner Vorstufen. München: W. Zuckschwerdt Verlag; 2009.
13. Royal College of Obstetricians and Gynaecologists: Guidelines for the Diagnosis and Management of Vulval Carcinoma, 2014. http://www.rcog.org.uk/womens-health/clinical-guidance/vulval-carcinoma-guidelines-diagnosisand-management.
14. American Joint Committee on Cancer. AJCC Cancer Staging Manual In. 6th ed., 2002. https://cancerstaging.org/references-tools/deskreferences/Pages/default.aspx.
15. Dignam JJ, Zhang Q, Kocherginsky M. The use and interpretation of competing risks regression models. Clin Cancer Res. 2012;18(8):2301-2308.
16. Wolbers M, Koller MT, Stel VS, et al. Competing risks analyses: objectives and approaches. Eur Heart J. 2014;35(42):2936-2941.
17. Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res. 2011;46(3):399-424.
18. Crowson CS, Schenck LA, Green AB, Atkinson EJ, Therneau T. The Basics of Propensity Scoring and Marginal Structural Models. Department of Health Sciences Research, Mayo Clinic Rochester, Minnesota;. In: Department of Health Sciences Research, Mayo Clinic Rochester, Minnesota, 2013.
19. Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
20. Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol. 1983;61(4):408-412.
21. Klemm P, Marnitz S, Kohler C, Braig U, Schneider A. Clinical implication of laparoscopic pelvic lymphadenectomy in patients with vulvar cancer and positive groin nodes. Gynecol Oncol. 2005;99(1):101-105.
22. Oonk MH, van Hemel BM, Hollema H, et al. Size of sentinelnode metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol. 2010;11(7):646-652.
23. Fons G, Groenen SMA, Oonk MHM, et al. Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. Gynecol Oncol. 2009;114(2):343-345.
24. Origoni M, Sideri M, Garsia S, Carinelli SG, Ferrari AG. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol Oncol. 1992;45(3):313-316.
25. van der Velden J, van Lindert AC, Lammes FB, et al. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival. Cancer. 1995;75(12):2885-2890.
26. Jones RW, Baranyai J, Stables S. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynecol. 1997;90(3):448-452.
27. Han SC, Kim DH, Higgins SA, Carcangiu ML, BM K. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiation Oncol Biol Phys. 2000;47(5):1235-1244.
28. Moore DH, Ali S, Koh WJ, et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locallyadvanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol. 2012;124(3):529-533.
29. Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiation Oncol Biol Phys. 1998;42(1):79-85.